{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreib7ds5zxlhhaw5bh6oqsfbdxdlexef6o2cjqiatcu2k2xltb7fduq",
    "uri": "at://did:plc:kpkcscbf2zshv7shqgqn45wn/app.bsky.feed.post/3mhqonaduzqv2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihbreltxisa6pq4praq63hlonc2iytsoelqdfxwogwi7546jo72ru"
    },
    "mimeType": "image/jpeg",
    "size": 1329
  },
  "path": "/story/385931/lyme-vaccine-shows-promise-but-tricky-path-lies-ahead.html",
  "publishedAt": "2026-03-23T12:30:00.000Z",
  "site": "https://www.newser.com",
  "textContent": "A potential comeback for a Lyme disease vaccine just cleared a big, but not decisive, hurdle. Pfizer and French drugmaker Valneva say their experimental shot cut Lyme infections by more than 70% in a late-stage trial of 9,400 people ages 5 and up—strong enough that they plan to...",
  "title": "Lyme Vaccine Shows Promise, but 'Tricky' Path Lies Ahead"
}